Simplovir 500 mg/vial (IV Infusion)
500 mg vial: ৳ 700.00
Medicine Details
Category | Details |
---|---|
Generic | Acyclovir injection |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Treatment of acute clinical manifestations of Herpes simplex virus in immunocompromised patients
- Treatment of severe primary or non-primary genital herpes in immune competent patients
- Treatment of Varicella zoster virus infection in immunocompromised patients
- Treatment of Herpes zoster (shingles) in immune competent patients with severe acute local or systemic manifestations
- Treatment of Herpes simplex encephalitis
Pharmacology
- Interferes with DNA synthesis
- Inhibits viral replication
- Antiviral activity against Herpes simplex virus
- Antiviral activity against Varicella zoster virus
- Requires intracellular conversion to Acyclovir Triphosphate for activity
Dosage
- 5 mg/kg every 8 hours for Herpes simplex infection
- 5 mg/kg every 8 hours for severe Herpes zoster infection
- 10 mg/kg every 8 hours for Varicella zoster infection
- 10 mg/kg every 8 hours for Herpes simplex encephalitis
- Each dose administered by slow intravenous infusion over a one-hour period
Administration
- Recommended duration of administration: 5 to 7 days for most infections
- Recommended duration of administration: at least 10 days for Herpes simplex encephalitis
- Administered via controlled-rate infusion pump or further diluted for administration by infusion
- Compatible with various infusion fluids
- Reconstituted and diluted solution to be used immediately and any unused solution to be discarded
Interaction
- Co-administration of probenecid increases mean half-life and area under the concentration time curve
- Concurrent use of diuretics increases plasma levels in patients over 60 years of age
Contraindications
- Hypersensitivity to Acyclovir or Valacyclovir
Side Effects
- Lethargy
- Confusion
- Reversible increases in liver-related enzymes
- Nausea
- Local inflammatory reactions if inadvertently infused into extracellular tissues
Pregnancy & Lactation
- Pregnancy category B
- Not recommended during pregnancy unless benefits clearly outweigh potential risks to fetus
- Administered to nursing mothers only if benefits to mother outweigh potential risks to the baby
Precautions & Warnings
- Intended for intravenous infusion only
- Reconstituted solution should not be administered by mouth
- Must be given over a period of at least one hour to avoid renal tubular damage
- Must be accompanied by adequate hydration
Use in Special Populations
- Pediatric use: dose calculated based on body surface area
- Pediatric dose for Herpes simplex and Varicella zoster infections: 250 mg/m2
- Geriatric use: special attention needed due to often low creatinine clearance
- Patients with renal impairment: dosage modifications recommended based on creatinine clearance
Overdose Effects
- Elevations of serum creatinine
- Neurological effects including confusion, seizures, and coma
- Adequate hydration essential to reduce possibility of crystal formation in urine
Therapeutic Class
- Treats Herpes simplex and Varicella-zoster virus infections
Duration of Treatment
- Recommended duration of administration: 5 to 7 days for most infections
- Recommended duration of administration: at least 10 days for Herpes simplex encephalitis
Reconstitution
- Each 250 mg vial reconstituted with 10 ml of Water for Injection or Sodium Chloride Intravenous Infusion (0.9% w/v)
- Each 500 mg vial reconstituted with 10 ml of Water for Injection or Sodium Chloride Intravenous Infusion (0.9% w/v)
Storage Conditions
- Store at 15°C to 25°C
- Protected from light and moisture
- Keep out of the reach of children
Related Brands
- Virunil 250 mg/vial (IV Infusion) - globe-pharmaceuticals-ltd
- Virux 500 mg/vial (IV Infusion) - square-pharmaceuticals-plc
- Xovir 250 mg/vial (IV Infusion) - beacon-pharmaceuticals-plc
- Xovir 500 mg/vial (IV Infusion) - beacon-pharmaceuticals-plc
- Virunil 500 mg/vial (IV Infusion) - globe-pharmaceuticals-ltd